Properties of a hepatitis A virus candidate vaccine strain
- PMID: 2821186
- DOI: 10.1099/0022-1317-68-9-2487
Properties of a hepatitis A virus candidate vaccine strain
Abstract
This paper describes the biophysical and biochemical properties as well as electron microscopical studies of a candidate hepatitis A vaccine strain propagated in human fibroblast cells. Our results indicated that, in CsCl, the density of hepatitis A virus (HAV) from cell culture supernatant and of HAV extracted from infected cells was influenced by the quantity of lipid material associated with HAV. Antigenicity of untreated HAV, therefore, was detected primarily in low density CsCl fractions (1.11 g/ml, 1.21 g/ml). After lipid reduction with NP40 detergent or chloroform/Genetron, antigenicity and infectivity were primarily detected in high density CsCl fractions (1.31 g/ml). Electron microscopy demonstrated a strong association between membranous material and virus particles of low density in CsCl as well as virus-like particles in ultrathin sections of HAV-infected human fibroblast cells. The uncovered virus particles banded in the 1.31 g/ml dense CsCl fraction lacked lipid material. The s value was 79 for 1.19 g/ml to 1.22 g/ml dense HAV and 147 for 1.29 g/ml to 1.33 g/ml HAV. Autoradiography of the radioiodinated dense HAV revealed some proteins with high Mr (120K to 67K) and others with low Mr (37K to 15K).
Similar articles
-
Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl.J Virol. 1985 Apr;54(1):78-85. doi: 10.1128/JVI.54.1.78-85.1985. J Virol. 1985. PMID: 2983123 Free PMC article.
-
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.J Gen Virol. 1985 Nov;66 ( Pt 11):2501-5. doi: 10.1099/0022-1317-66-11-2501. J Gen Virol. 1985. PMID: 2997380
-
Cyclic excretion of hepatitis A virus in experimentally infected chimpanzees: biophysical characterization of the associated HAV particles.J Med Virol. 1977;1(2):133-8. doi: 10.1002/jmv.1890010206. J Med Virol. 1977. PMID: 205631
-
Propagation of hepatitis A virus in human diploid fibroblast cells.Acta Virol. 1986 Nov;30(6):463-7. Acta Virol. 1986. PMID: 2881465
-
Demonstration of hepatitis A virus in cell culture by electron microscopy with immunoperoxidase staining.J Virol Methods. 1987 Mar;15(4):323-8. doi: 10.1016/0166-0934(87)90155-8. J Virol Methods. 1987. PMID: 3034945
Cited by
-
Clinical development of a new inactivated hepatitis A vaccine.Infection. 1996 Nov-Dec;24(6):447-58. doi: 10.1007/BF01713047. Infection. 1996. PMID: 9007593 Review. No abstract available.
-
A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.J Virol Methods. 2017 May;243:68-73. doi: 10.1016/j.jviromet.2017.01.018. Epub 2017 Jan 26. J Virol Methods. 2017. PMID: 28131867 Free PMC article.
-
Assessment of packed bed bioreactor systems in the production of viral vaccines.AMB Express. 2014 Apr 25;4:25. doi: 10.1186/s13568-014-0025-z. eCollection 2014. AMB Express. 2014. PMID: 24949260 Free PMC article.
-
Immune response to hepatitis A virus capsid proteins after infection.J Clin Microbiol. 1996 Mar;34(3):707-13. doi: 10.1128/jcm.34.3.707-713.1996. J Clin Microbiol. 1996. PMID: 8904442 Free PMC article.
-
Orthopoxvirus Purification for High Containment Laboratories.Methods Mol Biol. 2025;2860:149-156. doi: 10.1007/978-1-0716-4160-6_10. Methods Mol Biol. 2025. PMID: 39621266
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources